Pro Share Advisors LLC Rhythm Pharmaceuticals, Inc. Transaction History

Pro Share Advisors LLC

  • $39.7 Billion
  • Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 13,958 shares of RYTM stock, worth $784,858. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,958
Previous 10,916 27.87%
Holding current value
$784,858
Previous $448,000 63.17%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$40.81 - $55.0 $124,144 - $167,310
3,042 Added 27.87%
13,958 $731,000
Q2 2024

Aug 13, 2024
SELL
$35.41 - $44.37 $102,405 - $128,318
-2,892 Reduced 20.94%
10,916 $448,000
Q1 2024

May 08, 2024
BUY
$39.12 - $52.44 $59,736 - $80,075
1,527 Added 12.43%
13,808 $598,000
Q4 2023

Feb 14, 2024
BUY
$21.39 - $49.64 $40,341 - $93,621
1,886 Added 18.14%
12,281 $564,000
Q3 2023

Nov 13, 2023
BUY
$15.81 - $27.8 $537 - $945
34 Added 0.33%
10,395 $238,000
Q2 2023

Aug 10, 2023
BUY
$16.32 - $21.15 $169,091 - $219,135
10,361 New
10,361 $170,000
Q2 2022

Aug 01, 2022
SELL
$3.12 - $12.25 $42,010 - $164,946
-13,465 Closed
0 $0
Q1 2022

May 10, 2022
SELL
$6.13 - $12.24 $19,873 - $39,682
-3,242 Reduced 19.41%
13,465 $155,000
Q4 2021

Feb 08, 2022
BUY
$8.62 - $13.9 $2,861 - $4,614
332 Added 2.03%
16,707 $168,000
Q3 2021

Nov 12, 2021
SELL
$11.68 - $20.72 $47,596 - $84,434
-4,075 Reduced 19.93%
16,375 $214,000
Q2 2021

Aug 13, 2021
BUY
$18.52 - $22.55 $63,968 - $77,887
3,454 Added 20.32%
20,450 $400,000
Q1 2021

May 14, 2021
BUY
$20.25 - $39.49 $55,221 - $107,689
2,727 Added 19.11%
16,996 $362,000
Q4 2020

Feb 09, 2021
BUY
$21.17 - $32.61 $64,356 - $99,134
3,040 Added 27.07%
14,269 $424,000
Q3 2020

Nov 13, 2020
SELL
$18.13 - $30.61 $6,943 - $11,723
-383 Reduced 3.3%
11,229 $243,000
Q2 2020

Aug 03, 2020
BUY
$14.41 - $25.35 $167,328 - $294,364
11,612 New
11,612 $259,000
Q1 2020

May 15, 2020
SELL
$13.16 - $22.9 $177,291 - $308,508
-13,472 Closed
0 $0
Q4 2019

Feb 12, 2020
BUY
$19.53 - $25.5 $29,568 - $38,607
1,514 Added 12.66%
13,472 $309,000
Q3 2019

Nov 12, 2019
BUY
$18.62 - $24.51 $5,530 - $7,279
297 Added 2.55%
11,958 $258,000
Q2 2019

Aug 13, 2019
SELL
$21.11 - $28.48 $35,507 - $47,903
-1,682 Reduced 12.61%
11,661 $257,000
Q1 2019

May 15, 2019
BUY
$24.76 - $31.66 $1,906 - $2,437
77 Added 0.58%
13,343 $366,000
Q4 2018

Feb 14, 2019
BUY
$24.11 - $31.34 $319,843 - $415,756
13,266 New
13,266 $357,000

Others Institutions Holding RYTM

# of Institutions
192
Shares Held
67.3M
Call Options Held
834K
Put Options Held
78.6K
View Full List

About RHYTHM PHARMACEUTICALS, INC.

RYTM Quotes by TradingView
  • Ticker RYTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,720,000
  • Market Cap $3.13B
  • Description
  • Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...
More about RYTM
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email